VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation
Main Authors: | Marinova, Milka, Lütjohann, Dieter, Breuer, Olof, Kölsch, Heike, Westhofen, Philipp, Watzka, Matthias, Mengel, Martin, Stoffel-Wagner, Birgit, Hartmann, Gunther, Coch, Christoph, Oldenburg, Johannes |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer-Verlag
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572390/ |
Similar Items
-
Structural Modeling Insights into Human VKORC1 Phenotypes
by: Czogalla, Katrin J., et al.
Published: (2015) -
VKORC1 and VKORC1L1: Why do Vertebrates Have Two Vitamin K 2,3-Epoxide Reductases?
by: Oldenburg, Johannes, et al.
Published: (2015) -
Intake of Dietary Phylloquinone and Menaquinones and Risk of Stroke
by: Vissers, Linda E. T., et al.
Published: (2013) -
VKORC1 Haplotypes in patients treated with warfarin
by: Beshna, E, et al.
Published: (2010) -
GGCX and VKORC1 inhibit osteocalcin endocrine functions
by: Ferron, Mathieu, et al.
Published: (2015)